Concord Biotech Limited
Promoter holding in Concord Biotech Limited has stayed unchanged at 44.08% for the last 8 quarters on record (since Sep 2024).
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Jun '26 | 44.08%=0.00 | 55.92%=0.00 |
| Mar '26 | 44.08%=0.00 | 55.92%=0.00 |
| Dec '25 | 44.08%=0.00 | 55.92%=0.00 |
| Sep '25 | 44.08%=0.00 | 55.92%=0.00 |
| Jun '25 | 44.08%=0.00 | 55.92%=0.00 |
| Mar '25 | 44.08%=0.00 | 55.92%=0.00 |
| Dec '24 | 44.08%=0.00 | 55.92%=0.00 |
| Sep '24 | 44.08%=0.00 | 55.92%=0.00 |
Trend
- Over a longer period, promoter holding went from 44.08% in Sep 2023 to 44.08% in Jun 2026, with no overall change.
Compared with similar companies
Promoter holding in Concord Biotech Limited is lower than 75% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Concord Biotech Limited | 44.08% |
| Marksans Pharma Limited | 43.87% |
| Indegene Limited | 0.00% |
| Rainbow Children's Medicare Limited | 49.84% |
| Molbio Diagnostics Limited | 41.29% |
| Vijaya Diagnostic Centre Limited | 52.46% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Concord Biotech Limited's promoter holding?
Promoters held 44.08% of Concord Biotech Limited as of 30 Jun 2026, and the public held 55.92%.
Has Concord Biotech Limited's promoter holding increased?
No, it was unchanged in the quarter to Jun 2026.
Are any promoter shares of Concord Biotech Limited pledged?
No promoter shares are recorded as pledged.
How has Concord Biotech Limited's promoter holding changed over the years?
Over a longer period, promoter holding went from 44.08% in Sep 2023 to 44.08% in Jun 2026, with no overall change.
How does Concord Biotech Limited's promoter holding compare with similar companies?
Promoter holding in Concord Biotech Limited is lower than 75% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.